Sea buckthorn’s graded skin evidence is two human trials of oral oil, and a few small studies listed beside them are not graded. Yang 2009 found big instrument-measured gains with no oral placebo arm. Chan 2024 found smaller gains against a proper placebo, with industry funding. Read together they suggest a real, modest benefit over 12 weeks. Read separately, each one misleads in a different direction.
See the data behind this chart
| Measure | Yang 2009 (2 g/day, 3 mo, no placebo group) | Chan 2024 oil (0.5 g/day, 12 wk) | Chan 2024 placebo |
|---|---|---|---|
| Hydration | +48.6% (from baseline only) | +8.4% (beat placebo) | +0.8% |
| Elasticity | +25.8% (from baseline only) | +2.6% (from baseline only) | +1.4% |
| Collagen density | not measured | +10.1% (from baseline only) | +4.4% |
| Texture (score fell) | not measured | +14.1% (beat placebo) | +4.1% |
Yang 2009: the big numbers, the missing placebo
The two trials do not carry the same weight, and the first one shows why. Sixty women aged 50 to 70 were randomized into two arms of 30: one took 2 grams of oral sea buckthorn oil daily, the other applied a topical seed-oil cream, for three months. Skin was measured with instruments, not questionnaires: a Corneometer for hydration, a Cutometer for elasticity, image analysis for roughness.
The oral arm’s results made the marketing rounds for years: hydration up 33.6 percent at one month and 48.6 percent at three, elasticity up 16.3 and then 25.8 percent. Surface roughness also fell, a change the study did not find statistically significant.
The caveats decide how much of that to believe. The oral group was compared against a topical cream, not against a placebo, so expectation, attention, and seasonal effects had room to inflate the numbers. And the oil was SBA24, a branded ingredient from the company connected to the research. Real measurements, weak controls, interested money.
One more caveat deserves its own paragraph: the journal. Yang 2009 appeared in the Journal of Applied Cosmetology, which sits outside the PubMed index, so the paper skipped the indexing layer of quality control most of the corpus passed through. That does not make the measurements fake. It means one fewer independent screen stood between the data and you, and the reading-studies page treats that screen as its own check.
Chan 2024: the smaller, stricter answer
Forty healthy women, mean age about 52, took one 500 mg softgel of sea buckthorn oil or a placebo daily for 12 weeks, measured with a Corneometer, VISIA imaging and DermaLab instruments, with blood markers alongside.
The instruments matter here. A Corneometer measured hydration, VISIA imaging the pores and texture, and DermaLab the collagen density. They measure skin the way a blood test measures cholesterol, by instrument rather than opinion, which is what makes an 8 percent finding worth printing at all.
The results were quieter, and only two skin measures beat the placebo group: texture improved 14 percent, and hydration rose 8 percent, a comparison the authors only marked significant in a correction published in June 2024. Collagen density rose 10 percent and pore count fell 15 percent from baseline, but the placebo group’s collagen also rose 4.4 percent and neither measure separated from placebo. Blood work showed catalase up 82.8 percent against both baseline and placebo, HDL cholesterol up 14.8 percent with placebo also up 6.9 percent, and TNF-alpha down 23 percent without reaching significance. Most participants also reported ocular and vaginal symptom relief, the self-reported soft spot of the paper, and those scores didn’t differ from placebo either.
This trial was placebo-controlled and recent, which is what good looks like. It was also small and funded by Puredia, the oil’s maker, with three Puredia staff among the authors and a competing-interest statement that declares none, which is what caution looks like.
The blood markers need their own caution label. An 82.8 percent rise in catalase sounds dramatic, and it was an unregistered blood marker beside the seven skin measures the trial registered as its primary outcomes, in 40 people (20 on the oil), where one or two strong responders can bend an average. Secondary markers in small trials are hypothesis fuel, not findings, and the skin numbers, the trial’s actual job, were the modest ones.
The effect-size reality check
Put the two hydration numbers side by side: 48.6 percent against 8 percent. The instinct is to average them, and the discipline is to weight them. Yang’s number came from the 30 women in its oral arm, out of 60 enrolled and split against a topical cream, with no placebo arm, where expectation and attention leak into every measurement. Chan’s came from a placebo-controlled design, the stricter instrument, and stricter instruments almost always find smaller effects. An 8 percent hydration rise on a Corneometer is real and subtle: your skin holds measurably more water, and nobody across a room will notice. Plan for the strict number, and treat the loose one as the ceiling of the possible.
The elasticity and collagen numbers obey the same gravity. Yang’s 25.8 percent elasticity gain came from the loose design. Chan’s 10 percent collagen density gain came from the strict one. When a label quotes the big number, it is quoting the design with the weaker controls, and now you can see it. Chan also measured at week 4, where texture had already moved, but both trials stopped at the last dose, so both are silent about how long the shift survives the last capsule.
What a definitive trial would need
- Size: hundreds of participants, not 20 to 30 per arm, so modest effects stop wobbling.
- Independence: no branded oil, no manufacturer funding, replication by a lab with nothing to sell.
- A real placebo matched for color and taste, because an orange oil is hard to blind.
- Duration past 12 weeks, plus follow-up after stopping, to see whether gains persist or fade.
- Pre-registered endpoints, so the reported measures were chosen before the results arrived.
The independence bullet carries a price tag, which is why it stays a wish. A trial like that costs real money, academic grants rarely fund cosmetics-adjacent questions, and the companies with the budget are the companies whose funding discounts the result. The safety review notes that the same trial reports say little about adverse events, and the study dosages page holds the exact grams behind each arm.
Until that trial exists, the fair summary is: two trials, same direction, different magnitudes, and the stricter one found the smaller effect. For practical use, the skin hub maps which skin claims this supports and which it does not, and the clinical trials catalog places these two studies among the human studies in our registry.
The small studies we list and do not grade
Two kinds of small study sit beside the two graded trials. A 1999 trial gave 49 people with atopic dermatitis 5 grams a day of seed oil, pulp oil or paraffin oil for 4 months. Dermatitis improved significantly in the pulp-oil and paraffin-oil placebo groups and not significantly in the seed-oil group, and its abstract reports no comparison between groups. The other kind is a handful of small studies of topical fruit-extract creams and emulsions in healthy volunteers, mostly from one Pakistani group. Akhtar 2010 put a 1% extract cream on the cheeks of 10 volunteers for 8 weeks and reported lower sebum secretion than its base. Khan 2013 gave 11 men a 1% extract emulsion for 7 weeks and reported better skin mechanical parameters than the base. Khan 2014 gave 13 men a 5% extract emulsion for 84 days and reported better hydration and less water loss than the base. Ali 2011 applied a 1% extract cream to the cheeks of 21 volunteers for 8 weeks and reported less water loss and more skin water than the base. Kipić 2014 tested an emulsion with about 40% sea buckthorn oil in volunteers and on rabbit skin and reported more skin hydration and no irritation.
We could read only the abstracts, and nobody independent has repeated any of them. Most are extract or emulsion products and not the oral oil of the two graded trials, so we list them and do not grade them.
Oral oil versus cream, the question buyers actually ask
Yang’s design accidentally poses the question everyone asks: the trial compared swallowing the oil against spreading it on the face, in separate arms. That makes the two routes sound interchangeable, and they are not. The oral arm fed skin from the bloodstream, the cream arm worked the surface, and neither arm tells you anything about combining them or about which suits your skin. The graded human evidence for skin is an oral-oil file, the dry skin page and the wrinkles page both frame it that way, and topical products sit outside what either trial measured. So if you are buying to match the studied route, reach for an oral oil like the oils we scored highest, not a face cream neither graded trial tested.
Frequently asked questions
Is sea buckthorn oil clinically proven for skin?
Two graded human trials of the oral oil exist, both positive, both caveated. Yang 2009 measured hydration up about 49 percent and elasticity up about 26 percent at 2 grams daily over 3 months, but the oral arm had no placebo group. Chan 2024 measured more modest gains (texture up 14 percent and hydration up 8 percent against a real placebo at 500 mg daily over 12 weeks, while its 10 percent collagen density rise did not separate from placebo), with industry funding. Promising, not proven.
Which sea buckthorn skin study is more trustworthy?
They answer different questions. Yang 2009 shows the size of what might be possible, with weaker controls. Chan 2024 shows a smaller effect with a proper placebo, which is usually closer to the truth. Read together, the reasonable expectation is a modest, real hydration benefit over 12 weeks, measured on instruments, not a transformation. Elasticity rose in both trials, but in the controlled one the placebo group rose too.
Should I take the oil orally or apply it to skin?
The two graded trials answered the oral question, not the topical one. Both skin studies dosed oil by mouth, and Yang's topical cream arm was a comparator, not a validated treatment. If you want the studied route, it is 500 mg to 2 grams daily by mouth for 12 weeks. Topical use has tradition and cosmetic logic behind it, and a handful of small extract-cream studies in 10 to 21 volunteers that we list and do not grade.
Illustration.